Cargando…
PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027893/ https://www.ncbi.nlm.nih.gov/pubmed/31742794 http://dx.doi.org/10.1111/hae.13875 |
_version_ | 1783498928319102976 |
---|---|
author | Baumann, Andreas |
author_facet | Baumann, Andreas |
author_sort | Baumann, Andreas |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7027893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70278932020-02-24 PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety Baumann, Andreas Haemophilia Letters to the Editor John Wiley and Sons Inc. 2019-11-19 2020-01 /pmc/articles/PMC7027893/ /pubmed/31742794 http://dx.doi.org/10.1111/hae.13875 Text en © 2019 The Authors. Haemophilia published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Letters to the Editor Baumann, Andreas PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety |
title | PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety |
title_full | PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety |
title_fullStr | PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety |
title_full_unstemmed | PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety |
title_short | PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety |
title_sort | pegylated biologics in haemophilia treatment: current understanding of their long‐term safety |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027893/ https://www.ncbi.nlm.nih.gov/pubmed/31742794 http://dx.doi.org/10.1111/hae.13875 |
work_keys_str_mv | AT baumannandreas pegylatedbiologicsinhaemophiliatreatmentcurrentunderstandingoftheirlongtermsafety |